Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 24 Feb 2026 for RIGEL PHARMACEUTICALS INC, €82k.
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Walter H. Moos: trading record in brief
Walter H. Moos, listed as board member, appears in our data through filings on Rigel Pharmaceuticals Inc shares, published by SEC (Form 4). Between 26 June 2007 and 20 February 2026, the trades on record add up to 8 filings.
No open-market purchase appears, only 1 sale worth €124k. Other entries cover 5 share grants and 2 option exercises. Since January 2026: no purchases and 1 sale on the market.
Most recently, on 24 February 2026, the filings show an open-market sale worth €124k in Rigel Pharmaceuticals Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Walter H. Moos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
4,000 shares@ US$24.00100.0% of flowCommon StockSEC:0000905148-26-001015:0
2,500 shares0Common StockSEC:0000905148-25-001934:0
25,000 shares0Common StockSEC:0000905148-24-001655:0
25,000 shares0Common StockSEC:0001140361-23-034285:0
25,000 shares0Common StockSEC:0001140361-22-020308:0
25,000 shares0Common StockSEC:0001179110-21-005770:0
6 of 6 declarations
